SCHEMBL26201450

SCHEMBL26201450

CCC1CC(N)=Nc2c(ncn2[C@@H]2O[C@H](COP(=O)(O)O[C@H]3[C@@H](OC)[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]2O)C1=O

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FUT5 Q11128 1/20 0.58
TGM2 P21980 1/20 0.55
RNASEL Q05823 9/20 0.54
P2RY6 Q15077 2/20 0.53
P2RY2 P41231 1/20 0.53
P2RY4 P51582 1/20 0.53
KRAS P01116 2/20 0.53
NT5E P21589 1/20 0.51
IMPDH2 P12268 1/20 0.49
IMPDH1 P20839 1/20 0.49
DCPS Q96C86 1/20 0.48
ENPP1 P22413 1/20 0.48
P2RY1 P47900 1/20 0.48
P2RX1 P51575 1/20 0.48
P2RX3 P56373 1/20 0.48
P2RY11 Q96G91 1/20 0.48
P2RX4 Q99571 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26204432 0.88 TGM2 (0.68) FUT5TGM2RNASELP2RY6P2RY2
SCHEMBL26201436 0.88 TGM2 (0.68) FUT5TGM2RNASELP2RY6P2RY2
SCHEMBL22678637 0.85 TGM2 (0.69) FUT5TGM2RNASELP2RY6P2RY2
SCHEMBL26203966 0.85 FUT5 (0.58) FUT5TGM2RNASELP2RY6P2RY2
SCHEMBL26201883 0.85 FUT5 (0.58) FUT5TGM2RNASELP2RY6P2RY2
SCHEMBL26201887 0.85 RNASEL (0.73) FUT5TGM2RNASELP2RY2P2RY1
SCHEMBL26578079 0.85 RNASEL (0.73) FUT5TGM2RNASELP2RY2P2RY1
SCHEMBL26577103 0.85 RNASEL (0.73) FUT5TGM2RNASELP2RY2P2RY1
SCHEMBL26201639 0.85 RNASEL (0.73) FUT5TGM2RNASELP2RY2P2RY1
SCHEMBL24941695 0.84 RNASEL (0.72) TGM2RNASELP2RY2P2RY1P2RX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023159930-A1 COMPOUND FOR RNA CAPPING AND APPLICATION OF COMPOUND 广州市恒诺康医药科技有限公司 2023-08-31 WO disclosed